Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Bill to make insulin more affordable for Americans by limiting costs.
The problem
Insulin prices have risen sharply, making this life-saving medication unaffordable for many diabetic patients who need it regularly.
The proposal
The bill would cap insulin costs and increase affordability measures, though specific mechanisms are not yet detailed in available information.
The impact
Diabetic patients would pay less for insulin. Drug manufacturers and insurers would face new cost restrictions and regulations.
People with diabetes could afford their medication more easily. This would help prevent serious health problems from skipping doses due to cost.
Families struggling with insulin costs would have more money for other needs. Medical debt related to insulin would likely decrease.
When insulin costs less, people take it as prescribed. This prevents dangerous blood sugar complications and hospitalizations.
Better access to insulin improves outcomes for millions of Americans with diabetes. Healthcare system costs from complications would decrease.
Lower prices could reduce pharmaceutical company profits and investment in new insulin formulas. Future medical innovations might slow down.
Insurers might raise premiums elsewhere to cover insulin cost limits. Other healthcare services could become more expensive.
Creating price controls requires complex regulations and enforcement. Government agencies would need resources to monitor compliance.
Price controls could restrict which insulin types are available. Patients might not get their preferred medications.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.